Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025100 · ClinicalTrials.gov registry record
VTE Prophylaxis Guidelines in Hospitalized Elders
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 79
- Enrollment target
NCT03025100 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 79 participants.
The verdict
NCT03025100 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
Guideline directed use of pharmacologic Venous thromboembolism (VTE) prophylaxis emphasizes mobility evaluation. Mobility is a key component of risk stratification. Poor mobility evaluation by providers may be a significant barrier to appropriate use of VTE prophylaxis. The investigators aim is to propose to determine whether level of mobility during hospitalization is being used to influence use and duration of VTE prophylaxis among medically ill hospitalized elders. To achieve this aim, the investigator will collect prospective observational data to objectively measure inpatient mobility using patient mounted accelerometers during patient hospital stays. The investigator's goal is to improve the appropriateness of use of VTE prophylaxis among those in which the risks of harm may outweigh the benefit. Results from this study will provide important insights about use of risk assessment, and the relationship between patient mobility and VTE prophylaxis. These results are critical to understanding how to take the next steps toward improving the appropriate use and safety of anticoagulants in hospitalized older adults. Information from this study could be used in future proposals to study interventions to ultimately improve hospital practice in the care of older adults.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03025100
The ClinicalTrials.gov registry entry for NCT03025100 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03025100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03025100 about?
NCT03025100 is a clinical study titled "VTE Prophylaxis Guidelines in Hospitalized Elders". Guideline directed use of pharmacologic Venous thromboembolism (VTE) prophylaxis emphasizes mobility evaluation. Mobility is a key component of risk stratification. Poor mobility evaluation by providers may be a significant barrier to appropriate use of VTE prophylaxis. The investigators aim is to p...
What is the current status of trial NCT03025100?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2016-02. Estimated completion is 2017-03-04.
Who is sponsoring clinical trial NCT03025100?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.